Area of research
Molecular Biology · Oncology
Research interest
Research interests include Colorectal Cancer Surgical Treatments, RNA modifications and cancer, Bone Metabolism and Diseases, and Renal cell carcinoma treatment.
Immunometabolism: signaling pathways, homeostasis, and therapeutic targets
Expression and significance of Cystatin-C in clear cell renal cell carcinoma
The C-reactive protein/albumin ratio, a validated prognostic score, predicts outcome of surgical renal cell carcinoma patients
Preoperative serum cystatin-C as a potential biomarker for prognosis of renal cell carcinoma
Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation
Upregulation of PD-L1 by EML4-ALK fusion protein mediates the immune escape in ALK positive NSCLC: Implication for optional anti-PD-1/PD-L1 immune therapy for ALK-TKIs sensitive and resistant NSCLC patients
PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival